JP2024501286A5 - - Google Patents

Info

Publication number
JP2024501286A5
JP2024501286A5 JP2023538732A JP2023538732A JP2024501286A5 JP 2024501286 A5 JP2024501286 A5 JP 2024501286A5 JP 2023538732 A JP2023538732 A JP 2023538732A JP 2023538732 A JP2023538732 A JP 2023538732A JP 2024501286 A5 JP2024501286 A5 JP 2024501286A5
Authority
JP
Japan
Prior art keywords
human
nucleic acid
light chain
locus
segments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023538732A
Other languages
English (en)
Japanese (ja)
Other versions
JP7758739B2 (ja
JP2024501286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/064263 external-priority patent/WO2022140219A1/en
Publication of JP2024501286A publication Critical patent/JP2024501286A/ja
Publication of JP2024501286A5 publication Critical patent/JP2024501286A5/ja
Priority to JP2025087440A priority Critical patent/JP2025116078A/ja
Application granted granted Critical
Publication of JP7758739B2 publication Critical patent/JP7758739B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023538732A 2020-12-23 2021-12-20 アンカー改変型抗体をコードする核酸およびその使用 Active JP7758739B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025087440A JP2025116078A (ja) 2020-12-23 2025-05-26 アンカー改変型抗体をコードする核酸およびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063129893P 2020-12-23 2020-12-23
US63/129,893 2020-12-23
US202163219402P 2021-07-08 2021-07-08
US63/219,402 2021-07-08
PCT/US2021/064263 WO2022140219A1 (en) 2020-12-23 2021-12-20 Nucleic acids encoding anchor modified antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025087440A Division JP2025116078A (ja) 2020-12-23 2025-05-26 アンカー改変型抗体をコードする核酸およびその使用

Publications (3)

Publication Number Publication Date
JP2024501286A JP2024501286A (ja) 2024-01-11
JP2024501286A5 true JP2024501286A5 (OSRAM) 2024-12-27
JP7758739B2 JP7758739B2 (ja) 2025-10-22

Family

ID=80787529

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023538732A Active JP7758739B2 (ja) 2020-12-23 2021-12-20 アンカー改変型抗体をコードする核酸およびその使用
JP2025087440A Pending JP2025116078A (ja) 2020-12-23 2025-05-26 アンカー改変型抗体をコードする核酸およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025087440A Pending JP2025116078A (ja) 2020-12-23 2025-05-26 アンカー改変型抗体をコードする核酸およびその使用

Country Status (12)

Country Link
US (3) US20240317849A1 (OSRAM)
EP (2) EP4559939A3 (OSRAM)
JP (2) JP7758739B2 (OSRAM)
KR (1) KR20230125236A (OSRAM)
AU (1) AU2021410655A1 (OSRAM)
CA (1) CA3165366A1 (OSRAM)
ES (1) ES3025508T3 (OSRAM)
IL (1) IL303868A (OSRAM)
MX (1) MX2023007401A (OSRAM)
TW (1) TW202241934A (OSRAM)
WO (1) WO2022140219A1 (OSRAM)
ZA (1) ZA202305999B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026030428A2 (en) 2024-08-01 2026-02-05 Regeneron Pharmaceuticals, Inc. Prostate-specific antigen peptides and uses thereof
US20260123608A1 (en) 2024-08-06 2026-05-07 Regeneron Pharmaceuticals, Inc. Non-human animals having modified immunoglobulin heavy chain constant region locus and uses thereof
WO2026096736A1 (en) 2024-10-31 2026-05-07 Regeneron Pharmaceuticals, Inc. Rodents expressing humanized polymeric immunoglobulin receptor

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582A (en) 1850-08-20 Hot-air register
US298A (en) 1837-07-29 Process for purifying salt-water preparatory to manufacturing salt
ES2284161T3 (es) 1990-01-12 2007-11-01 Amgen Fremont Inc. Generacion de anticuerpos xenogenicos.
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5698679A (en) * 1994-09-19 1997-12-16 National Jewish Center For Immunology And Respiratory Medicine Product and process for targeting an immune response
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
ATE549918T1 (de) 1996-12-03 2012-04-15 Amgen Fremont Inc Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2002076196A1 (en) 2001-03-22 2002-10-03 Abbott Gmbh & Co. Kg Transgenic animals expressing antibodies specific for genes of interest and uses thereof
ATE386810T1 (de) * 2002-06-14 2008-03-15 Dyax Corp Rekombination von nukleinsäurebibliotheksmitgliedern
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
ES2707152T3 (es) 2005-04-15 2019-04-02 Macrogenics Inc Diacuerpos covalentes y usos de los mismos
US9963510B2 (en) 2005-04-15 2018-05-08 Macrogenics, Inc. Covalent diabodies and uses thereof
JP5514539B2 (ja) 2006-03-31 2014-06-04 メダレックス・リミテッド・ライアビリティ・カンパニー ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物
NZ587107A (en) 2006-06-02 2012-05-25 Regeneron Pharma High affinity antibodies to human il-6 receptor
US11535673B2 (en) * 2007-04-05 2022-12-27 President and Fellows of Harvard CoHege Chimeric activators: quantitatively designed protein therapeutics and uses thereof
CA2688834C (en) 2007-06-01 2020-01-07 Ronald Buelow Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
TWI476280B (zh) 2008-03-07 2015-03-11 Regeneron Pharma 來自二倍體宿主胚胎注射之es-細胞衍生的老鼠
RU2731084C2 (ru) 2008-06-27 2020-08-28 Мерюс Н.В. Продуцирующие антитела млекопитающие, не являющиеся человеком
WO2010039900A2 (en) 2008-09-30 2010-04-08 Aliva Biopharmaceuticals, Inc. Non-human mammals for the production of chimeric antibodies
EP2448966B1 (en) * 2009-07-03 2018-11-14 Avipep Pty Ltd Immuno-conjugates and methods for producing them
CN102638971B (zh) 2009-07-08 2015-10-07 科马布有限公司 动物模型及治疗分子
DK2509409T3 (en) 2009-12-10 2016-11-14 Regeneron Pharma MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES
US20120021409A1 (en) 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
HRP20151188T4 (hr) 2010-02-08 2021-10-01 Regeneron Pharmaceuticals, Inc. Miš sa zajedničkim lakim lancem
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
US20130185821A1 (en) 2010-02-08 2013-07-18 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
PL3251503T3 (pl) 2010-03-31 2024-07-08 Ablexis, Llc Modyfikacja myszy metodami inżynierii genetycznej w celu wytworzenia przeciwciał chimerycznych
SI2480675T1 (sl) 2010-06-22 2016-08-31 Regeneron Pharmaceuticals, Inc. Miši, ki izražajo lahko verigo s spremenljivo regijo humanega lambda in konstantno mišjo regijo
RU2580017C2 (ru) 2010-07-26 2016-04-10 Трианни, Инк. Трансгенные животные и способы применения
KR102306967B1 (ko) 2010-08-02 2021-10-01 리제너론 파아마슈티컬스, 인크. Vl 도메인을 포함하는 결합 단백질을 생성하는 마우스
LT2738259T (lt) 2011-02-25 2020-03-10 Regeneron Pharmaceuticals, Inc. Adam6 pelės
PT3865581T (pt) 2011-08-05 2024-10-04 Regeneron Pharma Murganhos da cadeia leve universal humanizada
AU2012311286B2 (en) 2011-09-19 2018-07-26 Kymab Limited Antibodies, variable domains and chains tailored for human use
CA2791109C (en) 2011-09-26 2021-02-16 Merus B.V. Generation of binding molecules
KR20140082824A (ko) 2011-10-17 2014-07-02 리제너론 파아마슈티컬스, 인크. 제한된 면역글로불린 중쇄 마우스
PL2773671T3 (pl) 2011-11-04 2022-01-24 Zymeworks Inc. Projekt stabilnego przeciwciała heterodimerycznego z mutacjami w domenie fc
MX353278B (es) 2012-03-06 2018-01-05 Regeneron Pharma Raton con cadena ligera comun.
HK1200271A1 (en) 2012-03-16 2015-08-07 瑞泽恩制药公司 Mice that produce antigen-binding proteins with ph-dependent binding characteristics
KR102213535B1 (ko) 2012-03-16 2021-02-08 리제너론 파마슈티칼스 인코포레이티드 pH-민감성 면역글로불린 서열을 발현하는 비-사람 동물
DK2825036T3 (en) 2012-03-16 2018-07-16 Regeneron Pharma Histidine engineered light chain antibodies and genetically modified rodents to generate them
US20140013456A1 (en) 2012-03-16 2014-01-09 Regeneron Pharmaceuticals, Inc. Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
KR20150023535A (ko) 2012-06-05 2015-03-05 리제너론 파마슈티칼스 인코포레이티드 공통 경쇄를 사용하여 완전한 인간 이중 특이적 항체를 만드는 방법
EP3912464A1 (en) * 2012-06-12 2021-11-24 Regeneron Pharmaceuticals, Inc. Humanized non-human animals with restricted immunoglobulin heavy chain loci
SG11201504676VA (en) 2012-12-14 2015-07-30 Omt Inc Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same
MY185881A (en) 2013-02-20 2021-06-14 Regeneron Pharma Non-human animals with modified immunoglobulin heavy chain sequences
EP4218409B1 (en) 2013-03-13 2025-02-12 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
JP2016519568A (ja) 2013-03-13 2016-07-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. 共通軽鎖のマウス
US9475559B2 (en) 2013-07-03 2016-10-25 Hobie Cat Company Foot operated propulsion system for watercraft
CN106255410B (zh) 2014-03-21 2020-01-10 瑞泽恩制药公司 产生单结构域结合蛋白的非人动物
RS60366B1 (sr) 2014-06-23 2020-07-31 Regeneron Pharma Sastavljanje dnk posredovano nukleazom
CA2968440A1 (en) 2014-11-21 2016-05-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification using paired guide rnas
US9410301B2 (en) 2014-12-09 2016-08-09 Theophile Bourgeois Patch system and method for oil boom
BR112017013104A2 (en) 2014-12-19 2018-05-15 Regeneron Pharmaceuticals, Inc. methods for modifying a target genomic locus in a cell, for enhancing homologous recombination at a target genomic locus in a cell, and for producing an f0 generation from a nonhuman animal.
US11111314B2 (en) 2015-03-19 2021-09-07 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
KR102483193B1 (ko) 2016-06-03 2023-01-04 리제너론 파마슈티칼스 인코포레이티드 외인성 말단 데옥시뉴클레오타이드 전달효소를 발현하는 비인간 동물
AU2017345764A1 (en) 2016-10-20 2019-05-02 Alpine Immune Sciences, Inc. Secretable variant immunomodulatory proteins and engineered cell therapy
PT4082334T (pt) 2016-11-04 2025-05-21 Regeneron Pharma Animais não humanos possuindo um lócus da cadeia leve lambda de immunoglobulina geneticamente modificada
CN207626880U (zh) 2017-05-19 2018-07-20 厦门汇成峰户外用品有限公司 一种导演椅
TW202438676A (zh) 2017-12-05 2024-10-01 美商再生元醫藥公司 具有經改造免疫球蛋白λ輕鏈的非人類動物及其用途
WO2020072937A1 (en) * 2018-10-04 2020-04-09 The Trustees Of The University Of Pennsylvania Antibodies against basement membrane zone adhesion proteins bp180 and bp230

Similar Documents

Publication Publication Date Title
DK2509409T3 (en) MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES
KR102116296B1 (ko) 일반적인 경쇄 마우스
CN104244709B (zh) 共同轻链小鼠
RU2017106292A (ru) Мыши, у которых вырабатываются связывающие белки, содержащие vl-домены
JP2017509355A5 (OSRAM)
US20090271880A1 (en) Binding molecules
WO2008122886A2 (en) Transgenic non-human mammal with homodimeric vh binding complex
JP2010527622A5 (OSRAM)
JP2021528057A5 (OSRAM)
KR102139388B1 (ko) 친화성 성숙 인간 항체의 동정
JP2024014897A (ja) 混合結合ドメイン
JP7758739B2 (ja) アンカー改変型抗体をコードする核酸およびその使用
US20250388651A1 (en) Transgenic chicken that makes antibodies with long cdr-h3s stabilized by multiple disulfide bridges and diversified by gene conversion
AU2019284255A1 (en) Transgenic chicken with functionally deleted IgY CH1 coding sequence
RU2023118544A (ru) Нуклеиновые кислоты, кодирующие модифицированные с помощью якоря антитела, и варианты их применения
JP2023540808A5 (OSRAM)
JP2021526830A5 (OSRAM)
JP7572861B2 (ja) 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生
RU2021131650A (ru) Отличные от человека животные, имеющие ограниченный репертуар легких лямбда-цепей, экспрессируемый из локуса капли, и их применение
JP2022535418A5 (OSRAM)
CN118496357A (zh) 一种多肽以及包含其作为轻链的抗体